BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Krittayaphong R, Chantrarat T, Rojjarekampai R, Jittham P, Sairat P, Lip GYH. Poor Time in Therapeutic Range Control is Associated with Adverse Clinical Outcomes in Patients with Non-Valvular Atrial Fibrillation: A Report from the Nationwide COOL-AF Registry. J Clin Med 2020;9:E1698. [PMID: 32498302 DOI: 10.3390/jcm9061698] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Phrommintikul A, Nathisuwan S, Gunaparn S, Krittayaphong R, Wongcharoen W, Sehmi S, Mehta S, Winkles N, Brocklehurst P, Mathers J, Jowett S, Jolly K, Lane D, Thomas GN, Lip GYH; TREATS-AF Study Group. Prospective randomised trial examining the impact of an educational intervention versus usual care on anticoagulation therapy control based on an SAMe-TT2R2 score-guided strategy in anticoagulant-naïve Thai patients with atrial fibrillation (TREATS-AF): a study protocol. BMJ Open 2021;11:e051987. [PMID: 34635526 DOI: 10.1136/bmjopen-2021-051987] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Apiyasawat S, Kornbongkotmas S, Chichareon P, Krittayaphong R; COOL‐AF Investigators. Mortality risk and temporal patterns of atrial fibrillation in the nationwide registry. J Arrhythm 2021;37:1434-42. [PMID: 34887947 DOI: 10.1002/joa3.12643] [Reference Citation Analysis]
3 Noviyani R, Youngkong S, Nathisuwan S, Bagepally BS, Chaikledkaew U, Chaiyakunapruk N, McKay G, Sritara P, Attia J, Thakkinstian A. Economic evaluation of direct oral anticoagulants (DOACs) versus vitamin K antagonists (VKAs) for stroke prevention in patients with atrial fibrillation: a systematic review and meta-analysis. BMJ Evid Based Med 2021:bmjebm-2020-111634. [PMID: 34635480 DOI: 10.1136/bmjebm-2020-111634] [Reference Citation Analysis]
4 Krittayaphong R, Winijkul A, Methavigul K, Sairat P, investigators COOLF, De Luca L. The Rate of Clinical Outcomes in Atrial Fibrillation according to Antithrombotic Strategy: The COOL-AF Registry. Cardiovascular Therapeutics 2022;2022:1-10. [DOI: 10.1155/2022/5797257] [Reference Citation Analysis]
5 Chantrarat T, Krittayaphong R. The Clinical Outcomes of Different eGFR Strata and Time in Therapeutic Range in Atrial Fibrillation Patients with Chronic Kidney Disease: A Nationwide Cohort Study. Curr Probl Cardiol 2021;46:100838. [PMID: 33992427 DOI: 10.1016/j.cpcardiol.2021.100838] [Reference Citation Analysis]
6 Suwanwela NC, Chutinet A, Autjimanon H, Ounahachok T, Decha-Umphai C, Chockchai S, Indrabhakti S, Kijpaisalratana N, Akarathanawat W, Travanichakul S, Kitjavijitre T, Vongvasinkul P, Kanacharoen I, Bunlikitkul TO, Charnwut S, Lowres N, Freedman B. Atrial fibrillation prevalence and risk profile from novel community-based screening in Thailand: A prospective multi-centre study. Int J Cardiol Heart Vasc 2021;32:100709. [PMID: 33490362 DOI: 10.1016/j.ijcha.2020.100709] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Wattanaruengchai P, Nathisuwan S, Karaketklang K, Wongcharoen W, Phrommintikul A, Lip GYH. Comparison of the HAS-BLED versus ORBIT scores in predicting major bleeding among Asians receiving direct-acting oral anticoagulants. Br J Clin Pharmacol 2021. [PMID: 34783372 DOI: 10.1111/bcp.15145] [Reference Citation Analysis]
8 Mitsuntisuk P, Nathisuwan S, Junpanichjaroen A, Wongcharoen W, Phrommintikul A, Wattanaruengchai P, Rattanavipanon W, Chulavatnatol S, Chaiyakunapruk N, Likittanasombat K, Lip GYH. Real-World Comparative Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants vs. Warfarin in a Developing Country. Clin Pharmacol Ther 2021;109:1282-92. [PMID: 33113153 DOI: 10.1002/cpt.2090] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
9 Yimer NS, Abiye AA, Hussen SU, Tadesse TA. Anticoagulation Control, Outcomes, and Associated Factors in Patients with Atrial Fibrillation Receiving Warfarin at Tertiary Care Hospital in Ethiopia. Clin Appl Thromb Hemost 2021;27:10760296211049786. [PMID: 34724849 DOI: 10.1177/10760296211049786] [Reference Citation Analysis]
10 Rivera‐caravaca JM, Gil‐perez P, Lopez‐garcía C, Veliz‐martínez A, Quintana‐giner M, Romero‐aniorte AI, Fernandez‐redondo C, Muñoz L, Quero E, Esteve‐pastor MA, Lip GYH, Roldán V, Marín F. A nurse‐led atrial fibrillation clinic: Impact on anticoagulation therapy and clinical outcomes. Int J Clin Pract 2020;74. [DOI: 10.1111/ijcp.13634] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]